Edition:
United States

Pfizer Inc (PFE)

PFE on New York Consolidated

36.74USD
22 Jul 2016
Change (% chg)

$0.03 (+0.08%)
Prev Close
$36.71
Open
$36.80
Day's High
$36.84
Day's Low
$36.68
Volume
13,481,509
Avg. Vol
35,659,751
52-wk High
$37.19
52-wk Low
$28.25

PFE

Chart for PFE

About

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. Its portfolio includes medicines, vaccines and medical devices, as well as consumer healthcare products. Its products include Prevnar/Prevenar 13, Lyrica, Enbrel, Lipitor,... (more)

Overall

Beta: 0.83
Market Cap(Mil.): $222,822.59
Shares Outstanding(Mil.): 6,064.85
Dividend: 0.30
Yield (%): 3.27

Financials

  PFE Industry Sector
P/E (TTM): 30.11 35.74 36.72
EPS (TTM): 1.22 -- --
ROI: 5.56 15.07 14.32
ROE: 11.65 16.13 15.54

BRIEF-Pfizer gets WHO prequalification for multi-dose vial presentation of Prevenar 13

* Pfizer receives world health organization prequalification for multi-dose vial presentation of Prevenar 13

Jul 19 2016

DEALTALK-Old pharma sees new profit cure in cancer drugs

July 19 Some of the world's largest drug companies are taking out their checkbooks for acquisitions of smaller peers whose cancer drugs have the potential to cure not just patients, but corporate growth prospects as well.

Jul 19 2016

Old pharma sees new profit cure in cancer drugs

Some of the world's largest drug companies are taking out their checkbooks for acquisitions of smaller peers whose cancer drugs have the potential to cure not just patients, but corporate growth prospects as well.

Jul 19 2016

DEALTALK-Old pharma sees new profit cure in cancer drugs

July 19 Some of the world's largest drug companies are taking out their checkbooks for acquisitions of smaller peers whose cancer drugs have the potential to cure not just patients, but corporate growth prospects as well.

Jul 19 2016

SoftBank to buy UK chip designer ARM in $32 billion cash deal

TOKYO/LONDON Japan's SoftBank will buy Britain's most valuable technology company ARM for $32 billion in cash, an audacious attempt to lead the next wave of digital innovation with a chip designer that powers the global mobile phone industry. | Video

Jul 18 2016

BRIEF-Pfizer publishes results from two Pivotal phase 3 studies of crisaborole topical ointment

* Pfizer announces publication of final results from two pivotal Phase 3 studies of crisaborole topical ointment in patients with mild to moderate atopic dermatitis

Jul 13 2016

FDA expands use of Pfizer's best-selling pneumonia vaccine

Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.

Jul 12 2016

FDA expands use of Pfizer's best-selling pneumonia vaccine

July 12 Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.

Jul 12 2016

BRIEF-Pfizer receives FDA approval for Prevnar 13

* Pfizer receives FDA approval for Prevnar 13 in adults age 18 through 49 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jul 12 2016

Exclusive: WellCare, Centene make offers for Aetna assets - sources

WellCare Health Plans Inc and Centene Corp have made competing offers for the Medicare Advantage insurance plans that Aetna Inc looks to shed in seeking clearance for its acquisition of Humana Inc , people familiar with the matter said. | Video

Jul 11 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $125.03 -0.12
Novartis AG (NOVN.S) CHF82.35 +0.40
Merck & Co., Inc. (MRK.N) $58.82 +0.03
Roche Holding Ltd. (ROG.S) CHF249.80 -0.20
Roche Holding Ltd. (RO.S) CHF252.25 +0.50
Abbott Laboratories (ABT.N) $43.17 +0.13
Bayer AG (BAYGn.DE) €92.07 +0.03
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.60 +0.38
AstraZeneca plc (AZN.L) 4,612.50p +89.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.